首页> 外文学位 >Screening natural products for chemopreventive agents based on binding RXRalpha and alkylation of Keap 1.
【24h】

Screening natural products for chemopreventive agents based on binding RXRalpha and alkylation of Keap 1.

机译:基于结合RXRalpha和Keap 1的烷基化作用筛选天然化学预防剂。

获取原文
获取原文并翻译 | 示例

摘要

Although there is no 'magic bullet' that can completely conquer cancer, many types of the disease might be avoidable. The chemoprevention of cancer, which uses pharmacological agents to impede, arrest or reverse carcinogenesis at its earliest stages, has great scientific promise. Natural products including plant and marine organisms are important sources of new chemopreventive agents but pose significant analytical challenges. The development of new mass spectrometric capabilities provide opportunities to speed up this natural product screening and drug discovery process for cancer chemoprevention agents. The advantage of mass spectrometry based screening method is that it can provide structural information of the hit compound in the screening process.;Mass spectrometry is ideal for studying interactions between small molecules and proteins. Cancer chemopreventive and treatment agents can function by interacting with functional proteins either through non-covalent binding or covalent modification which could both be studies using mass spectrometry. In this dissertation, two mass spectrometry-based assays were employed for screening botanical extracts for potential chemoprevention agents targeting functional proteins by either interaction.;(1) Screening marine extracts for ligands binding to human retinoid X receptor alpha (hRXRalpha) using ultrafiltration LC-MS-MS. A novel assay was developed and optimized. Structures of potential ligands of hRXRalpha-LBD from marine organism were characterized.;(2) Screening marine extracts for phase II inducers targeting human kelch-like ECH-associated protein 1 (hKeap1) by covalent modification. Ligustilide and its oxidative product from Angelica sinensis were confirmed as phase II enzyme inducers targeting hKeap1. To support mechanistic studies of how a phase II enzyme inducers up-regulate phase II genes, the relative reactivities of the cysteine residues in hKeap1 were profiled.
机译:尽管没有可以完全战胜癌症的“魔术弹”,但许多类型的疾病还是可以避免的。化学预防癌症,在早期阶段就使用药理药物阻止,阻止或逆转癌变,具有重大的科学前景。包括植物和海洋生物在内的天然产物是新的化学预防剂的重要来源,但构成了重大的分析挑战。新质谱功能的发展为加速癌症化学预防剂的天然产物筛选和药物发现过程提供了机会。基于质谱的筛选方法的优点是可以在筛选过程中提供目标化合物的结构信息。质谱是研究小分子与蛋白质相互作用的理想选择。癌症化学预防剂和治疗剂可以通过非共价结合或共价修饰与功能蛋白相互作用来发挥功能,这两种方法均可使用质谱进行研究。本文采用两种基于质谱的分析方法通过两种相互作用来筛选植物提取物中潜在的靶向功能蛋白的化学预防剂。(1)使用超滤LC-方法筛选海洋提取物中与人类维生素A X受体α(hRXRalpha)结合的配体。 MS-MS。开发和优化了一种新的测定法。表征了来自海洋生物的hRXRalpha-LBD潜在配体的结构。(2)通过共价修饰筛选针对人类海藻样ECH相关蛋白1(hKeap1)的II期诱导物的海洋提取物。当归中的gust本内酯及其氧化产物被证实是靶向hKeap1的II期酶诱导剂。为了支持有关II期酶诱导剂如何上调II期基因的机理研究,分析了hKeap1中半胱氨酸残基的相对反应性。

著录项

  • 作者

    Liu, Dongting.;

  • 作者单位

    University of Illinois at Chicago.;

  • 授予单位 University of Illinois at Chicago.;
  • 学科 Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 2008
  • 页码 98 p.
  • 总页数 98
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号